http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-800529-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b3d6aa79d32a3cccdfe41f6984e2d43
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-84
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-84
filingDate 1957-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1958-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-800529-A
titleOfInvention Improvements relating to the manufacture of organic hydroxylamine compounds
abstract Hydrogenation catalysts used in the production of aliphatic and cycloaliphatic hydroxylamines from the corresponding nitro-compounds may either be a mixture of the oxides or silver and chromium with or without another metal such as cobalt, copper, lead, cadmium, aluminium, iron, thorium and preferably manganese, or a mixture of the oxides of silver and manganese with or without the oxide of another metal such as chromium, lead, cobalt, copper, cadmium, and preferably nickel or zinc. A stabilizer such as barium or calcium oxide may also be present. The catalysts of the first type may be prepared by adding an ammoniacal solution of an alkali metal bichromate dropwise to the metal nitrates dissolved in water at 60-80 DEG C. The mixture is then cooled and the precipitate filtered and dried at 100 DEG C. The catalyst may be treated with acetic acid. The active catalysts are obtained by drying at room temperature in a vacuum. The ratio of silver nitrate to manganese nitrate is preferably between 5 and 40 per cent by weight. The content of alkaline earth metal nitrate should not exceed about 10 per cent by weight. The second type of catalyst may be prepared by treating an aqueous solution zinc and barium nitrate and potassium permanganate with an aqueous solution of silver and manganese nitrate at 60-80 DEG C. and filtering the precipitate. The catalyst may be dried or decomposed at elevated temperature or treated with acetic acid. The ratio of silver nitrate to zinc nitrate calculated as silver is preferably between 5 and 30 per cent by weight.ALSO:Aliphatic and cycloaliphatic hydroxylamines are prepared by catalytic hydrogenation of the corresponding nitro compounds, in the liquid phase, according to which the process is carried out at a temperature below 90 DEG C. and a pressure above 50 atmospheres in the presence of a mixed catalyst comprising silver oxide and one or more heavy metal oxides. The hydrogenation may be carried out with or without a solvent such as methanol, ethanol, cyclohexane, dioxane or tetrahydrofurane. The concentration of solvent is preferably between 5 and 20 per cent by weight of the nitro compounds. Small amounts of oximes and amines are also formed during the reaction. The process is preferably carried out in a reaction vessel kept at elevated temperature and hydrogen is circulated through the mixture of nitro compound, hydroxylamine, oxime, amine and catalyst. The reaction solution may then be continuously removed being replaced by a fresh solution of the nitro compound. The reaction solution may then be worked up by removing the catalyst, removing the solvent if necessary, cooling the residual solution and filtering the crystallized hydroxylamine. The mother liquor can again be returned to the hydrogenation process. The hydrogenation is preferably interrupted when 80-90 per cent of the nitro compound has been used. The catalyst may either be a mixture of the oxides of silver and chromium with or without another metal such as cobalt, copper, lead, cadmium, aluminium, iron, thorium and preferably manganese, or a mixture of the oxides of silver and manganese, with or without another metal such as chromium, lead, cobalt, copper, cadmium and preferably nickel or zinc. A mixture of the two types of catalyst may also be used. A stabilizer such as barium or calcium oxide may also be present in either case. The amount of catalyst required is between 2 and 20 per cent by weight of the nitro compound. Examples are given of the preparation of isopropylhydroxylamine together with small amounts of acetoxime and isopropylamine, and cyclohexylhydroxylamine together with small amounts of cyclohexylamine and cyclohexanoneoxime.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4622427-A
priorityDate 1956-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452754495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451110572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458391437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458391465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449824900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450868169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9794626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411295773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412550040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451518796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421354001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453530231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438

Total number of triples: 81.